Status:

WITHDRAWN

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Lead Sponsor:

Asociación para Evitar la Ceguera en México

Conditions:

Diabetic Retinopathy

Eligibility:

All Genders

18-80 years

Phase:

PHASE3

Brief Summary

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In compli...

Eligibility Criteria

Inclusion

  • Advanced diabetic retinopathy with retinal detachment

Exclusion

  • Retinal detachments of more than 6 months

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2006

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00407108

Start Date

March 1 2006

End Date

June 1 2006

Last Update

May 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"

Mexico City, Mexico DF, Mexico, 04030

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy | DecenTrialz